The Joslin Diabetes Center Diabetes Research Center (DRC) offers Pilot and Feasibility Grants in research areas directly related to diabetes, including types 1 and 2 diabetes and their complications, from basic, translational or clinical perspectives. Two P&F grants are offered for up to $50,000 per year and two years duration.
The awards provide funding either to new investigators (but not fellows) who have not yet received significant NIH or other support, or to more established investigators who are doing work in these areas for the first time. "New investigators" are defined as having an academic appointment associated with independent space and an independent project.
We encourage the submission of translational research projects, in particular new collaborative projects between a PI who is a basic scientist and a PI who is a clinician or clinical scientist. These projects must focus on patients or patient samples -- studies on mice or other model systems are not eligible for translational P&F awards. At least one of the two collaborating PIs must be from Joslin. If you are applying for this paired Basic/Clinical award, please specify this within the "Intended Proposal."
The application process is a two-step procedure. The potential candidate should submit an electronic "Intended Proposal" by midnight of Friday, September 15th, 2017. Received Intended Proposals will be pre-reviewed for eligibility and priority, and the successful candidates will be asked to electronically submit a five-page proposal following an abbreviated version of a standard NIH application, due by Friday, October 13th, 2017. After review the awarded P&Fs will be eligible for funding to start on January 1, 2018.
Please see "FAQs" page for any additional questions.
For further questions about the grant and the application process, email:
Deadline for Letter of Intent:
Friday September 15, 2017
Deadline for Full Application (invitation only): Friday October 13, 2017
Begins January 1, 2018
and lasts 1 year. A second year of funding is contingent upon positive review of the P&F year 1 progress report.